A study by Calkins et al. found that CD4 count decline associated with cancer treatment was concerning for persons with HIV, and immunosuppression in persons with HIV driven by cancer treatment, rather than the HIV disease process, could result in an increased risk of mortality [30]. This evidence concerns the gene CD4 and cancer.